Serap ÖZDEMİR
Gaziantep, 27000, Turkey (Türkiye)
NCT Number: NCT04962113
The study was conducted as a randomized controlled study to determine effect of tube bathing on skin and bilirubin levels in infants undergoing tunnel and LED of phototherapy. The population of the study consisted of term babies with the diagnosis of hyperbilirubinemia in Gaziantep Cengiz Gökçek Maternity and Pediatrics Hospital and Kilis State Hospital Neonatal Intensive Care Units (NICU) among November 2019-September 2020. The sample size was composed of a total of 140 babies, which were determined according to Power Analysis and met the case selection criteria. Accordingly, Thirty-five babies were randomly assigned to each group (Tunnel Group = experiment and control; LED Group = experiment and control). The babies in the experimental groups were given a tube bath at 6 and 12 hours after phototherapy started. On the other hand, the babies in the control groups were given routine cares in the units. Data were gathered 'Information and Registration Form', Neonatal Skin Risk Assessment Scale (NSRAS) and Neonatal Skin Condition Score (NSCS).
Looking for future studies?
Notify Me0 day–1 month
Female
Interventional
Not applicable
Gaziantep, 27000, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wrap Tube Baht (immersion)
Time frame: 1-2 month
The sample size was composed of a total of 140 babies, which were determined according to Power Analysis and met the case selection criteria.
Time frame: 1 month
Thirty-five babies were randomly assigned to each group (Tunnel Group = experiment and control; LED Group = experiment and control).
Time frame: 12 month
The babies in the experimental groups were given a tube bath at 6 and 12 hours after phototherapy started. On the other hand, the babies in the control groups were given routine cares in the units.
Time frame: First, 6-12-24 hours for each nerwborn
Data were gathered 'Information and Registration Form', Neonatal Skin Risk Assessment Scale (NSRAS) and Neonatal Skin Condition Score (NSCS).
Time frame: First, 6-12-24 hours for each nerwborn
Total serum bilirubin values obtained from patient files.
Time frame: 10 month
When differences regarding decrease in 24-hour total serum bilirubin (TSB) levels were compared in all relevant experimental groups, statistically differences were observed (p˂ .001). In particular, the levels of bilirubin were listed as LED-trial, Tunnel-trial, Tunnel-control and LED-control, respectively. It is worthy to utter herein that the decline in TSB was more notable in bathing groups.
Time frame: 10 month
Skin integrity and moisture balance were better in bathing groups than control groups, the best was in the Tunnel-experimental group and the worst was in the Tunnel-control group (p˂ .001).
Time frame: 12 month
Tube bath is suggested that decreasing total serum bilirubin level and maintaining skin integrity and moisture balance.
Istanbul University - Cerrahpasa
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06921330
ABO Incompatibility, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT06209489
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Karabük, Turkey (Türkiye)
View Trial DetailsNCT06058910
Brain Diseases, Brain Diseases, Metabolic
Kettering, Ohio, United States
View Trial DetailsNCT05692648
Bilirubinemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Konya, Selcuklu/Konya, Turkey (Türkiye)
View Trial Details